Ian Johnson

Ian Roy Johnson was the founder of Biotrace International Plc, founded in 1999, where the title held was Chief Executive Officer from 1999 to 2006.
Current jobs include Non-Executive Chairman at Niox Group Plc starting in 2025, Director at NIOX Healthcare Ltd. starting in 2020, Senior Independent Non-Executive Director at Induction Healthcare Group Plc starting in 2022, Member at The Institute of Directors, Member at Institute of Biology, Operational Advisor Biomedical at Harwood Private Equity, and Member at Royal Society of Biology.
Former jobs include Chief Executive Officer & Director at Big Technologies Plc from 2025 to 2026, Non-Executive Chairman at Cyprotex Ltd. from 2013 to 2016, Non-Executive Chairman at Ascendx Spine, Inc., Non-Executive Chairman at EAG Ltd. from 2007 to 2008, Executive Chairman at Bioquell Ltd. from 2016 to 2019, Chairman at Development Bank of Wales Plc, Chairman at Evans Analytical Group LLC from 2007 to 2008, Chairman at Lumora Ltd., Chairman at Biofortuna Ltd., Non-Executive Chairman at Celsis Group Ltd. from 2009 to 2015, Independent Non-Executive Chairman at Redcentric Plc from 2019 to 2021, Non-Executive Chairman at Quantum Pharma Holdings Ltd. from 2016 to 2017, Non-Executive Director at Ruskinn Technology Ltd., Director at Prosonix Ltd., Director at Bioquell UK Ltd., Non-Executive Director at MyCelx Technologies Corp.
from 2011 to 2013, Non-Executive Director at Toximet Ltd., Senior Independent Non-Executive Director at Clinigen Ltd. from 2021 to 2022, Director at Klenitise Ltd., Non-Executive Director at Ergomed Group Ltd. from 2019 to 2021, and Director at Aoi Medical, Inc. Education includes undergraduate and graduate degrees from the University of Cardiff.